youtube_live
Q3 2026 earnings • in 2 days
See detailschevron_right
ALC:NYSE
Alcon AG
$74.60
arrow_downward
-0.45%(-0.34) 1D
Nov 9, 11:42:58 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$74.62
High
$75.02
Low
$74.28
Mkt. cap
30.74B
Avg. vol.
1.86M
Volume
935.86K
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
Open
$74.62
High
$75.02
Low
$74.28
Mkt. cap
30.74B
Avg. vol.
1.86M
Volume
935.86K
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
BigGo Finance
·
57 minutes ago
US Stocks Rebound Sharply, Dow Briefly Up More Than 600 Points as Falling Oil Prices and Oversold Sentiment Provide Support
Yahoo Finance
·
1 hour ago
Morgan Stanley Says S&P 500 Correction Is In Its ‘Final Innings,’ Calls Chip Selloff An ‘Entry Point’
Bespoke Investment Group
·
1 hour ago
Bespoke | My Research
Quartz
·
2 hours ago
Dow jumps more than 600 points as oil slides and Nvidia stock falls
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorHealth Care
IndustryMedical device
Websitealcon.com